BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9349479)

  • 1. Inhibition of Moloney murine leukaemia virus by a retroviral vector, LNL6, carrying ribozymes targeted to the 5' non-coding sequence.
    Lowenstein P; Symonds G
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2587-90. PubMed ID: 9349479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
    Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication.
    Joshi S; Ding SF; Liem SE
    Nucleic Acids Res; 1997 Aug; 25(16):3199-203. PubMed ID: 9241231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
    Bender MA; Palmer TD; Gelinas RE; Miller AD
    J Virol; 1987 May; 61(5):1639-46. PubMed ID: 3502707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
    Xing Z; Mahadeviah S; Whitton JL
    Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
    Torrent C; Gabus C; Darlix JL
    J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of retroviral RNA packaging.
    Aronoff R; Linial M
    J Virol; 1991 Jan; 65(1):71-80. PubMed ID: 1985218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
    Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
    Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
    Parthasarathi S; Varela-Echavarría A; Ron Y; Preston BD; Dougherty JP
    J Virol; 1995 Dec; 69(12):7991-8000. PubMed ID: 7494312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo.
    Ramezani A; Joshi S
    Antisense Nucleic Acid Drug Dev; 1996; 6(3):229-35. PubMed ID: 8915508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions.
    Adam MA; Miller AD
    J Virol; 1988 Oct; 62(10):3802-6. PubMed ID: 3418786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses.
    Hatzoglou M; Hodgson CP; Mularo F; Hanson RW
    Hum Gene Ther; 1990; 1(4):385-97. PubMed ID: 1964095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.
    Sullenger BA; Cech TR
    Science; 1993 Dec; 262(5139):1566-9. PubMed ID: 8248806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral pseudo-virus carrying the envelope proteins of neurotropic Friend murine leukemia virus effectively transferred retroviral vector into glial cells.
    Ikeda T; Takase-Yoden S; Watanabe R
    Virus Res; 1996 Jun; 42(1-2):97-106. PubMed ID: 8806177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus.
    Fisher J; Goff SP
    Virology; 1998 Apr; 244(1):133-45. PubMed ID: 9581786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.
    Ramezani A; Ma XZ; Ameli M; Arora A; Joshi S
    Front Biosci; 2006 Sep; 11():2940-8. PubMed ID: 16720366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer.
    Ban J; First NL; Temin HM
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():1987-93. PubMed ID: 2549178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.
    Han L; Yun JS; Wagner TE
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4313-7. PubMed ID: 2034674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of retroviral vectors with enhanced efficiency of transgene expression.
    Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
    J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.